Amanta Healthcare concludes investor meeting with ValPro Capital
Amanta Healthcare officials held a virtual investor meeting with ValPro Capital on July 9, 2026. The interaction involved sharing publicly available information, with no Unpublished Price Sensitive Information disclosed. The disclosure was made under Regulation 30 of the SEBI Listing Obligations Regulations.

*this image is generated using AI for illustrative purposes only.
Amanta Healthcare officials interacted with ValPro Capital during a virtual investor meeting held on July 9, 2026, at 05:00 P.M. IST. The company confirmed that only publicly available information was shared during the session and no Unpublished Price Sensitive Information (UPSI) was discussed.
The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This meeting follows an earlier intimation dated July 6, 2026, regarding the scheduled interaction.
| Date | Particulars of Investor | Time | Type of Meeting |
|---|---|---|---|
| Thursday, July 9, 2026 | ValPro Capital | 05:00 P.M. | Virtual |
The company requested the exchange to take the outcome of the meeting on record.
Historical Stock Returns for Amanta Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.00% | +0.49% | +9.51% | +58.86% | +21.40% | +21.40% |
What specific growth strategies did Amanta Healthcare highlight during the meeting?
How might ValPro Capital's interest influence Amanta Healthcare's future investor relations?
What are the potential market reactions to this investor interaction?































